Trazodone promotes sleep primarily by blocking a specific serotonin receptor (called 5-HT2A) along with histamine and adrenaline-related receptors in the brain, and it does this at doses far lower than those needed to treat depression. Though the drug was originally approved as an antidepressant in the 1970s, roughly three-quarters of all trazodone prescriptions in the United States are now written for insomnia and other sleep problems. The story of how a depression medication became America’s most commonly prescribed sleep aid involves some interesting pharmacology, a favorable side-effect profile compared to older options, and a few genuine concerns worth understanding.
Why a Low Dose Puts You to Sleep
Trazodone’s sleep-promoting effect comes from its ability to block several receptors at once. At low doses, between about 25 and 100 mg, the drug powerfully blocks 5-HT2A serotonin receptors, H1 histamine receptors, and alpha-1 adrenergic receptors. Each of these contributes to wakefulness, so blocking all three at the same time produces noticeable sedation.1CNS Spectrums. Mechanism of Action of Trazodone: a Multifunctional Drug The histamine blockade is similar to what makes older antihistamines drowsy, while the alpha-1 blockade lowers arousal and blood pressure slightly. Together, these actions create a sedative effect that kicks in well before the drug starts doing much to serotonin reuptake, which is the mechanism responsible for its antidepressant properties.
To actually function as an antidepressant, trazodone needs to saturate the serotonin transporter, and that requires doses in the 150 to 600 mg range. At the 25 to 100 mg doses typically prescribed for sleep, the serotonin transporter is barely affected.2Psychopharmacology Institute. Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects – Section: Pharmacodynamics and mechanism of action This is why your doctor might describe low-dose trazodone as a sleep aid rather than an antidepressant, even though the pill bottle says “antidepressant” on it. The drug is essentially doing a different job at a different dose.
The Most Popular Sleep Drug You Have Never Heard Of
Trazodone’s dominance in insomnia treatment surprises most people, partly because it has never been officially approved by the FDA for that purpose. In 2019, roughly 24 million trazodone prescriptions were filled in the U.S., and at least 85% of them were for off-label indications, predominantly insomnia. Among all drugs prescribed specifically for an insomnia diagnosis, trazodone came in first at about 26% of prescriptions, edging out zolpidem (the active ingredient in Ambien) at 20%.3Oxford Academic (Health Affairs Scholar). Off-label policy through the lens of trazodone usage and spending in the United States There are practical reasons for this popularity: trazodone is generic, inexpensive, and not classified as a controlled substance, which makes prescribers more comfortable writing it than a benzodiazepine or a Z-drug like zolpidem.
A systematic review of the available evidence concluded that there are adequate data supporting both the efficacy and general safety of low-dose trazodone for insomnia, whether the insomnia is a standalone condition or occurs alongside depression, dementia, or other disorders.4PubMed Central. Trazodone for Insomnia: A Systematic Review That said, some researchers point out that while systematic reviews support trazodone’s use, a meta-analysis of randomized placebo-controlled trials found that the most consistent measurable benefit was a reduction in the number of nighttime awakenings, with other outcomes like total sleep time and time to fall asleep not always reaching statistical significance against placebo.5PubMed. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials The evidence is solid enough to justify widespread prescribing, but it is not as airtight as many people assume for a drug this commonly used.
What Trazodone Does to Your Sleep Stages
One of trazodone’s more appealing characteristics is the way it reshapes sleep architecture. A meta-analysis of polysomnographic studies found that trazodone increased total sleep time by about 40 minutes, decreased the time it took to fall into sustained sleep by roughly 19 minutes, cut down on nighttime awakenings, and reduced the amount of time spent awake after initially falling asleep.6Scientific Reports. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis It also significantly increased the deepest stage of non-REM sleep (often called slow-wave sleep or N3), which is the phase associated with physical restoration and memory consolidation.
An earlier study confirmed this boost to slow-wave sleep and noted that trazodone reduced the amount of time spent in REM sleep while taking the drug, with a rebound increase in REM above baseline levels after stopping.7PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration That REM rebound is worth knowing about: if you stop trazodone abruptly after using it for a while, you may experience vivid dreams or temporarily disrupted sleep as REM bounces back. The same study noted that people felt their sleep quality improved on trazodone even when objective measurements of total sleep duration didn’t always change dramatically, which hints that the drug’s real strength may lie in improving sleep depth and continuity rather than simply adding hours.
The meta-analysis found no significant effect on REM sleep as a proportion of total sleep, which contrasts slightly with the older single-study finding. This likely reflects the difference between a controlled lab study and a pooled analysis across many conditions and doses. The consistent finding across both, though, is that trazodone boosts deep sleep and reduces fragmentation, both of which matter more for how rested you feel than raw hours in bed.6Scientific Reports. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis
How Trazodone Compares to Other Common Sleep Medications
A head-to-head comparison of trazodone, doxepin, and melatonin for sleep disorders in psychiatric patients found that trazodone produced the largest improvement in sleep quality scores at six months, with about 76% of participants rated as improved. Doxepin came close in terms of sleep-quality improvement and had a somewhat better tolerability profile, while melatonin was slightly less effective but caused the fewest side effects, including the lowest rates of morning grogginess and daytime drowsiness.8PubMed Central. Addressing Sleep Disorders in Psychiatry: Comparing the Use of Melatonin, Trazodone, and Doxepin
This pattern captures trazodone’s general position in the sleep-medication landscape: it tends to work well for sleep quality but comes with more side effects than the gentlest alternatives. Against benzodiazepines and Z-drugs, trazodone’s advantage is largely about safety. It carries a much lower risk of dependence and withdrawal, and it is not a controlled substance. Against milder options like melatonin, trazodone is the more potent sleep aid but comes with trade-offs like morning grogginess, orthostatic hypotension (a drop in blood pressure when you stand up), and occasional dizziness.
Side Effects at Sleep Doses
At the 25 to 100 mg doses used for sleep, trazodone is generally well tolerated, but “well tolerated” does not mean free of side effects. A meta-analysis focused on depressive patients taking trazodone found significantly elevated rates of daytime somnolence, sedation, and blurred vision compared to placebo.9SpringerLink / Psychopharmacology. The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials Morning grogginess is the most commonly reported complaint and affected about 15% of users in the comparative trial mentioned above.8PubMed Central. Addressing Sleep Disorders in Psychiatry: Comparing the Use of Melatonin, Trazodone, and Doxepin Taking trazodone too late at night or at a dose higher than you need worsens this hangover effect.
Orthostatic hypotension, where your blood pressure drops when you go from lying down to standing, is another consequence of the alpha-1 receptor blockade. About 10% of users in the comparative study experienced this. For most younger adults, it means a brief head rush when getting out of bed. For older adults, it can mean a serious fall risk. Dry mouth, mild headache, and occasional nausea round out the common side effects at low doses.
One rare but serious side effect worth mentioning is priapism, a prolonged and painful erection unrelated to sexual stimulation. It’s extremely uncommon but requires immediate medical attention. This risk tends to get flagged prominently in drug information leaflets, which can be alarming. In practice, the incidence is very low at sleep doses, but anyone experiencing an erection lasting several hours should go to an emergency room.
Timing, Half-Life, and the Morning-After Question
Trazodone has a relatively short half-life of about 3 to 9 hours, which supports the common practice of taking it at bedtime.10PubMed. Trazodone dosing regimen: experience with single daily administration This half-life is short enough that the drug should be mostly cleared by morning, but the wide range means some people metabolize it more slowly than others. If you find yourself groggy well into the next day, you may be a slower metabolizer, and a lower dose or earlier bedtime dose could help.
Taking trazodone on a completely empty stomach leads to faster and higher peak blood levels, which can intensify both the sedative effect and the blood pressure drop. Many clinicians recommend taking it with a small snack to blunt the peak slightly. This is one of those practical tips that doesn’t always make it into the prescribing information but can make a real difference in how the drug feels.
Tolerance, Dependence, and Getting Off Trazodone
One of the main reasons clinicians reach for trazodone over benzodiazepines or Z-drugs is its lower potential for abuse and physical dependence. A disproportionality analysis of the FDA’s adverse event reporting system found that benzodiazepines had the highest rates of abuse, dependence, and withdrawal reports, followed by trazodone and then Z-drugs. Newer orexin receptor antagonists (DORAs) had significantly lower odds of abuse-related adverse events compared to both Z-drugs and trazodone.11Frontiers in Pharmacology. Real-world data on the abuse potential of medications for the treatment of insomnia: a disproportionality analysis of the FAERS database
So trazodone isn’t completely free of dependence signals in real-world data, but it sits well below benzodiazepines and is not a controlled substance. In practice, most people can stop trazodone without severe withdrawal, though a gradual taper over a week or two is generally recommended rather than abrupt cessation. As noted earlier, stopping suddenly can trigger a REM rebound that temporarily makes sleep feel worse and dreams more intense. This isn’t dangerous, but it can be unpleasant enough that people mistakenly believe they’ve become dependent on the drug when they’ve really just hit a transient sleep disruption.
Trazodone in Older Adults
Older adults are the demographic most likely to receive trazodone for sleep, and also the demographic most vulnerable to its side effects. The alpha-1 receptor blockade that causes orthostatic hypotension is particularly dangerous in this group because blood pressure drops can lead to falls. A large administrative database study comparing older adults with insomnia who were treated with zolpidem, trazodone, or benzodiazepines found that patients receiving benzodiazepines or trazodone had the greatest fall risk in adjusted analyses.12PubMed Central. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines
This puts trazodone in a complicated position for geriatric care. It avoids the cognitive suppression and dependence risk of benzodiazepines, which is why many geriatricians prefer it, but it introduces its own fall hazard through blood pressure drops. The practical takeaway for older adults or their caregivers: start at the lowest possible dose (often 25 mg), make sure there is a clear path from bed to bathroom at night, sit on the edge of the bed for a moment before standing, and report any dizziness to the prescribing doctor.
What About Next-Day Thinking and Driving?
Residual cognitive effects are a real concern with any sleep medication. A study of trazodone in people with primary insomnia found small but statistically significant impairments in short-term memory, verbal learning, balance, and arm muscle endurance. However, the same study found no significant impairment in simulated driving performance or speeding behavior.13PubMed Central. Cognitive, Psychomotor, and Polysomnographic Effects of Trazodone in Primary Insomniacs A separate study looking at repeated dosing in healthy volunteers found that trazodone did not affect driving performance or cognitive function under either acute or repeated administration.14PubMed. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers
The picture is somewhat reassuring but not entirely clean. Minor memory and learning effects existed in one study, while another found nothing. The difference likely comes down to dosing, timing of testing relative to when the drug was taken, and individual variation. If your job demands sharp recall early in the morning, this is worth monitoring during the first few weeks on trazodone. Most people at sleep doses do not experience meaningful next-day cognitive problems, but the subset who metabolize the drug slowly could.
Heart Rhythm Considerations
Trazodone can prolong the QT interval on an electrocardiogram, a measure of how long the heart takes to electrically reset between beats. A formal study using intravenous trazodone at three escalating doses found that the QT prolongation was dose-dependent: about 4.5 milliseconds at a low dose, roughly 12 milliseconds at a moderate dose, and close to 20 milliseconds at a high dose.15PubMed Central. Effect of 3 Single Doses of Trazodone on QTc Interval in Healthy Subjects At the low oral doses used for sleep, the QT effect is modest and not considered clinically dangerous for most people.
That said, there are case reports of serious cardiac arrhythmias, including torsades de pointes, in patients taking trazodone. In one published case, a woman taking just 50 mg daily developed a dangerously prolonged QT interval and experienced a life-threatening arrhythmia requiring defibrillation.16PubMed Central. Torsades de Pointe Associated with Trazodone Consumption Cases like these are rare and typically involve additional risk factors such as electrolyte imbalances, other QT-prolonging medications, or pre-existing heart conditions. If you have a history of heart rhythm problems, or if you take other medications known to affect the QT interval, this is something your doctor should be aware of before starting trazodone.
The mCPP Metabolite and Why It Matters
When your liver breaks down trazodone, one of the byproducts is a compound called meta-chlorophenylpiperazine (mCPP). This metabolite has its own pharmacological activity, acting as a serotonin receptor agonist with various neuropsychiatric effects including influences on mood, body temperature, and hormone release.17PubMed. Metabolism of m-CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects Interestingly, mCPP has been studied as a recreational substance because of its stimulant-like properties.
The relevant finding for sleep is that mCPP actually disrupts sleep rather than promoting it. In a study where mCPP was given to healthy volunteers at night, five out of six subjects reported prominent behavioral and psychological effects that interfered with sleep, a stark contrast to the sedative effect of its parent compound, trazodone. The researchers concluded that trazodone’s hypnotic effect is not related to mCPP’s activity.18Biological Psychiatry. A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers In practical terms, this metabolite is produced in small amounts and doesn’t seem to undermine trazodone’s sleep benefits at standard doses. But people who take CYP enzyme inhibitors (certain antifungals, some antibiotics, grapefruit juice in large amounts) may slow the metabolism of trazodone and potentially alter the balance between the parent drug and mCPP, which is one more reason to keep your prescriber informed about all medications and supplements you’re taking.
When Trazodone Pulls Double Duty for Sleep and Depression
For people who have both depression and insomnia, trazodone occupies a unique niche. Evidence supports the use of low-dose trazodone as a sleep aid for patients already being treated for major depressive disorder, and the drug’s ability to improve sleep can complement the effects of a primary antidepressant like an SSRI.19PubMed Central. Rediscovering trazodone for the treatment of major depressive disorder This “add-on” use is common: a patient takes their main antidepressant in the morning and a low dose of trazodone at bedtime to address the insomnia that often accompanies depression or that SSRIs themselves can cause.
If you’re on an SSRI or SNRI and your doctor adds trazodone for sleep, the combination is generally considered safe at low trazodone doses, though both drugs affect serotonin, and the theoretical risk of serotonin syndrome exists. In practice, serotonin syndrome from this combination at typical sleep doses is quite rare, but symptoms like agitation, rapid heart rate, muscle twitching, or fever should prompt immediate medical attention.
Immediate-Release Versus Extended-Release Formulations
Most trazodone prescribed for sleep is the standard immediate-release tablet, which is cheap and widely available. An extended-release formulation (marketed under different brand names depending on the country) was developed mainly for depression, using doses of 150 to 375 mg. In its clinical trial for depression, the extended-release version also showed improvements in sleep quality as a secondary outcome.20PubMed Central. Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study
For sleep alone, the immediate-release version at a low dose is the standard approach. The extended-release formulation spreads the drug’s absorption out over a longer period, which is useful if you need steady antidepressant blood levels throughout the day but counterproductive if you just want a quick onset of sedation at bedtime. Some patients who wake in the middle of the night and cannot return to sleep might theoretically benefit from an extended-release version, but this is not a well-studied use, and the cost is significantly higher than the generic immediate-release tablet. In most cases, if your doctor is prescribing trazodone solely for sleep, the immediate-release form is the right choice.